Literature DB >> 3963972

Group G streptococcal infections.

K V Rolston.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3963972

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  8 in total

1.  Phage 3396 from a Streptococcus dysgalactiae subsp. equisimilis pathovar may have its origins in streptococcus pyogenes.

Authors:  Mark R Davies; David J McMillan; Gary H Van Domselaar; Malcolm K Jones; Kadaba S Sriprakash
Journal:  J Bacteriol       Date:  2007-01-26       Impact factor: 3.490

2.  LY146032 compared with penicillin G in experimental aortic valve endocarditis caused by group G streptococci.

Authors:  A S Bayer; J Yih; L Hirano
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

3.  Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis.

Authors:  N J Martin; E L Kaplan; M A Gerber; M A Menegus; M Randolph; K Bell; P P Cleary
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

4.  Infective endophthalmitis due to Group G Streptococcal infection in a patient with metastatic ovarian carcinoma.

Authors:  Rachel Christine Steckelberg; Amy T Wang; Walter Wilson
Journal:  BMJ Case Rep       Date:  2011-08-19

5.  Group G streptococcal lymphadenitis in rats.

Authors:  B F Corning; J C Murphy; J G Fox
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

6.  Comparative genomic analysis of the Streptococcus dysgalactiae species group: gene content, molecular adaptation, and promoter evolution.

Authors:  Haruo Suzuki; Tristan Lefébure; Melissa Jane Hubisz; Paulina Pavinski Bitar; Ping Lang; Adam Siepel; Michael J Stanhope
Journal:  Genome Biol Evol       Date:  2011-01-31       Impact factor: 3.416

7.  Gene repertoire evolution of Streptococcus pyogenes inferred from phylogenomic analysis with Streptococcus canis and Streptococcus dysgalactiae.

Authors:  Tristan Lefébure; Vince P Richards; Ping Lang; Paulina Pavinski-Bitar; Michael J Stanhope
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

8.  Engineered Liposomes Protect Immortalized Immune Cells from Cytolysins Secreted by Group A and Group G Streptococci.

Authors:  Hervé Besançon; Yu Larpin; Viktoria S Babiychuk; René Köffel; Eduard B Babiychuk
Journal:  Cells       Date:  2022-01-05       Impact factor: 6.600
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.